Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Proceeds from Issuance or Sale of Equity

1.8 / 5 stars · 32/87 Roast Me

Co-Diagnostics, Inc. Proceeds from Issuance or Sale of Equity

Co-Diagnostics, Inc. (CODX) reported Proceeds from Issuance or Sale of Equity of $1.00 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2019-08-14

  • Co-Diagnostics, Inc. proceeds from issuance or sale of equity for the quarter ending 2019-06-30 was $0.00.
  • Co-Diagnostics, Inc. proceeds from issuance or sale of equity for the quarter ending 2019-03-31 was $1.00M.
Period endProceeds from Issuance or Sale of Equity 3 monthProceeds from Issuance or Sale of Equity 6 month
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.00M
10-Q · filed 2019-08-14
2019-03-31$1.00M
10-Q · filed 2019-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01